The Association for Accessible Medicines (AAM) invited Dr. Keith D. Gallicano, Novum’s Chief Scientific Officer to be a panelist at the GRx +Biosims Conference on September 5-7, 2018 in Baltimore, MD.
Dr. Gallicano was a panelist on: “OLD, NEW, AND FUTURE CHALLENGES IN BIOEQUIVALENCE” on September 7th, 2018, from 11:00 am to 12:00 pm. This session provided an overview of bioequivalence, its historic implications, the new challenges that have recently emerged, as well as new issues that are looming on the horizon.
Members of Novum’s leadership team, including CEO Christopher H. Chamberlain, and executives from Scientific Affairs, Operations, Business Development and Regulatory Affairs attended the GRx +Biosims Conference. In addition, Novum sponsored the conference luncheon for the 6th year in a row.